Gold(III)-dithiocarbamato peptidomimetics in the forefront of the targeted anticancer therapy: preclinical studies against human breast neoplasia.
about
Transition Metal Intercalators as Anticancer Agents-Recent AdvancesInhibition of 19S proteasome-associated deubiquitinases by metal-containing compoundsTrailing TRAIL Resistance: Novel Targets for TRAIL Sensitization in Cancer CellsNew bipyridine gold(III) dithiocarbamate-containing complexes exerted a potent anticancer activity against cisplatin-resistant cancer cells independent of p53 statusGold(III) complexes in medicinal chemistry.Gold(III)-pyrrolidinedithiocarbamato Derivatives as Antineoplastic Agents.Copper Ion Attenuated the Antiproliferative Activity of Di-2-pyridylhydrazone Dithiocarbamate Derivative; However, There Was a Lack of Correlation between ROS Generation and Antiproliferative Activity.Metal-based proteasomal deubiquitinase inhibitors as potential anticancer agents.Targeting the ubiquitin-proteasome system for cancer treatment: discovering novel inhibitors from nature and drug repurposing.Phosphanegold(I) thiolates, Ph3PAu[SC(OR)=NC 6H 4Me-4] for R = Me, Et and iPr, induce apoptosis, cell cycle arrest and inhibit cell invasion of HT-29 colon cancer cells through modulation of the nuclear factor-κB activation pathway and ubiquitinatioIn vitro antibacterial and time-kill evaluation of phosphanegold(I) dithiocarbamates, R3PAu[S2CN(iPr)CH2CH2OH] for R = Ph, Cy and Et, against a broad range of Gram-positive and Gram-negative bacteria
P2860
Q28077365-341AA684-061A-4B8B-84A9-2F86724D0D7DQ28082497-E0A404F3-1E27-4068-81ED-A3949B7E0F06Q28391040-51ACE882-8C33-4E49-BDBD-0154A0C90E65Q37686897-0D09ACDF-1610-4A6E-9468-E0B6B3EC9DF6Q38264535-172EB9D4-507E-452D-A9AA-C6542ECF3966Q40298546-EAE00321-F32A-4FE3-BE76-EF61DB3E89C3Q46497562-1CE45BB0-3B74-4693-8CA6-A536D70BA1A2Q47098444-F4C12FFB-858C-4DB0-A154-80DF1A43C073Q47631097-2BDB5D0E-E80D-4F06-8C1C-7DE0B30179ADQ52804185-72DB6AF8-0DE7-4081-A7E7-CE43FF0A1C79Q59319251-583C745E-2D7A-4477-9D79-AF919BE71F82
P2860
Gold(III)-dithiocarbamato peptidomimetics in the forefront of the targeted anticancer therapy: preclinical studies against human breast neoplasia.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Gold(III)-dithiocarbamato pept ...... gainst human breast neoplasia.
@ast
Gold(III)-dithiocarbamato pept ...... gainst human breast neoplasia.
@en
type
label
Gold(III)-dithiocarbamato pept ...... gainst human breast neoplasia.
@ast
Gold(III)-dithiocarbamato pept ...... gainst human breast neoplasia.
@en
prefLabel
Gold(III)-dithiocarbamato pept ...... gainst human breast neoplasia.
@ast
Gold(III)-dithiocarbamato pept ...... gainst human breast neoplasia.
@en
P2093
P2860
P1433
P1476
Gold(III)-dithiocarbamato pept ...... against human breast neoplasia
@en
P2093
Dolores Fregona
Huanjie Yang
Q Ping Dou
Sara M Schmitt
P2860
P304
P356
10.1371/JOURNAL.PONE.0084248
P407
P577
2014-01-02T00:00:00Z